醒脑静注射液联合依达拉奉注射液治疗急性脑出血40例疗效分析

目的观察醒脑静注射液联合依达拉奉注射液治疗急性脑出血的疗效。方法将120例急性脑出血患者随机分为醒脑静组40例,依达拉奉组40例及醒脑静联用依达拉奉组(联合组)40例,分别给予相应的处置。治疗前及治疗3周后,对3组患者的血肿吸收情况、神经功能缺损评分(NIH评分)、Barthel指数进行评定。结果联合组治疗后,血肿均明显吸收、NIH评分明显降低、BI评分明显升高,联合组改善情况优于醒脑静组和依达拉奉组(P<0.01)。结论醒脑静注射液联合依达拉奉注射液,能明显促进急性脑出血患者病情的恢复。

Analysis on Xingnaojing Injection Associated with Edaravone Injection in Treatment of Acute Cerebral Hemorrhage of 40 Cases

Objective To observe Xingnaojing injection associated with edaravone injection treatment of acute cerebral hemorrhage.Methods 120 patients were randomly divided into Xingnaojing group of 40 cases,40 cases of edaravone group,Xingnaojing associated edaravone group(combined group) 40 cases,were given appropriate disposal.Pre-treatment and treatment three weeks later,three groups of patients with hematoma absorption,the neurological deficit score(NIH score),the Barthel Index were assessed.Results Thehematoma in combination group after treatment were significantly absorbed,the NIH score was significantly lower and BI scores were significantly increased.The improved cases injoint groupbetter than Xingnaojing group and the edaravone group(P<0.01).Conclusion Xingnaojing injection associated with edaravone injection can significantly promote the recovery of the disease in patients with acute cerebral hemorrhage.